Email ID
Password
Scrip   
Memantine filed for Alzheimer's disease in Japan
09 February 2010
Ian Haydock

Daiichi Sankyo's Asubio Pharma subsidiary has submitted an approval application in Japan for memantine for the treatment of Alzheimer's disease.

The NMDA receptor antagonist is licensed from Merz Pharma and has been under development in Japan for both mild-to-moderate and severe forms...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36